COMORBIDITIES IN PULMONARY ARTERIAL HYPERTENSION (PAH): INSIGHTS FROM THE REAL-WORLD OPSUMIT® USERS (OPUS) REGISTRY

2020 
Many patients with PAH have comorbidities that may exclude them from clinical trials due to stringent inclusion criteria. The OPUS Registry ([NCT02126943][1]) is an ongoing, prospective, multicenter, US drug registry of patients newly treated with macitentan. Here, patient and disease
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []